Your browser doesn't support javascript.
loading
Patients with both pancreatic adenocarcinoma and melanoma may harbor germline CDKN2A mutations.
Lal, G; Liu, L; Hogg, D; Lassam, N J; Redston, M S; Gallinger, S.
Affiliation
  • Lal G; Department of Surgery, University of Toronto, Toronto, Ontario, Canada.
Genes Chromosomes Cancer ; 27(4): 358-61, 2000 Apr.
Article in En | MEDLINE | ID: mdl-10719365
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Adenocarcinoma / Germ-Line Mutation / Cyclin-Dependent Kinase Inhibitor p16 / Melanoma / Neoplasms, Multiple Primary Type of study: Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Genes Chromosomes Cancer Journal subject: BIOLOGIA MOLECULAR / NEOPLASIAS Year: 2000 Document type: Article Affiliation country: Canada Country of publication: United States
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Adenocarcinoma / Germ-Line Mutation / Cyclin-Dependent Kinase Inhibitor p16 / Melanoma / Neoplasms, Multiple Primary Type of study: Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Genes Chromosomes Cancer Journal subject: BIOLOGIA MOLECULAR / NEOPLASIAS Year: 2000 Document type: Article Affiliation country: Canada Country of publication: United States